Medical Ikkou Group Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Nov'25

Aug'25

May'25

Feb'25

Nov'24

Aug'24

May'24

Net Sales

13,933.16

13,512.03

13,423.45

13,303.10

12,424.94

11,481.68

11,183.77

Other Operating Income

0.00

Total Operating income

13,933.16

13,512.03

13,423.45

13,303.10

12,424.94

11,481.68

11,183.77

Raw Material Cost

12,284.53

12,001.99

11,875.73

11,738.60

11,064.85

10,157.24

9,826.99

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

27.90

24.35

21.87

19.29

17.59

13.35

13.62

Selling and Distribution Expenses

1,164.01

1,201.06

1,113.09

1,075.70

985.18

925.32

927.58

Other Expenses

-2.79

-2.44

-2.19

-1.93

-1.76

-1.34

-1.36

Total Expenditure (Excl Depreciation)

13,448.54

13,203.05

12,988.81

12,814.30

12,050.03

11,082.56

10,754.57

Operating Profit (PBDIT) excl Other Income

484.6

309

434.6

488.8

374.90000000000003

399.09999999999997

429.20000000000005

Other Income

30.25

170.46

216.25

76.47

75.40

81.16

147.86

Operating Profit (PBDIT)

733.92

686.02

846.57

778.74

648.50

661.13

747.95

Interest

27.90

24.35

21.87

19.29

17.59

13.35

13.62

Exceptional Items

-3.88

-84.56

36.82

-213.71

0.00

-1.77

108.00

Gross Profit (PBDT)

1,648.63

1,510.04

1,547.73

1,564.50

1,360.09

1,324.44

1,356.78

Depreciation

219.06

206.58

195.68

213.46

198.20

180.86

170.89

Profit Before Tax

483.08

370.52

665.84

332.29

432.71

465.15

671.45

Tax

192.24

133.09

212.03

214.78

131.01

172.81

235.87

Provisions and contingencies

0.00

Profit After Tax

280.01

228.65

438.21

133.86

289.80

280.18

429.33

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

280.01

228.65

438.21

133.86

289.80

280.18

429.33

Share in Profit of Associates

0.00

Minority Interest

10.84

8.78

15.60

-16.36

11.90

12.16

6.25

Other related items

0.00

Consolidated Net Profit

290.85

237.43

453.81

117.50

301.70

292.34

435.57

Equity Capital

0.00

Face Value

0.0

Reserves

14,817.47

14,636.60

14,304.10

14,097.86

13,960.99

13,775.77

13,579.42

Earnings per share (EPS)

74.35

60.74

116.49

35.58

77.04

74.52

114.24

Diluted Earnings per share

74.35

60.74

116.49

35.58

77.04

74.52

114.24

Operating Profit Margin (Excl OI)

3.48%

2.29%

3.24%

3.67%

3.02%

3.48%

3.84%

Gross Profit Margin

5.04%

4.27%

6.42%

4.1%

5.08%

5.63%

7.53%

PAT Margin

2.01%

1.69%

3.26%

1.01%

2.33%

2.44%

3.84%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Nov 2025 is 3.12% vs 0.66% in Aug 2025

Consolidate Net Profit

QoQ Growth in quarter ended Nov 2025 is 22.49% vs -47.69% in Aug 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Nov 2025 is 36.48% vs -18.20% in Aug 2025

Interest

QoQ Growth in quarter ended Nov 2025 is 14.34% vs 11.42% in Aug 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025

Compare Quarterly Results Of Medical Ikkou Group Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

13,933.16

24,490.00

-10,556.84

-43.11%

Other Operating Income

0.00

Total Operating income

13,933.16

24,490.00

-10,556.84

-43.11%

Raw Material Cost

12,284.53

17,950.00

-5,665.47

-31.56%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

27.90

55.00

-27.10

-49.27%

Selling and Distribution Expenses

1,164.01

6,153.00

-4,988.99

-81.08%

Other Expenses

-2.79

-5.50

2.71

49.27%

Total Expenditure (Excl Depreciation)

13,448.54

24,103.00

-10,654.46

-44.20%

Operating Profit (PBDIT) excl Other Income

484.62

387.00

97.62

25.22%

Other Income

30.25

50.00

-19.75

-39.50%

Operating Profit (PBDIT)

733.92

821.00

-87.08

-10.61%

Interest

27.90

55.00

-27.10

-49.27%

Exceptional Items

-3.88

-421.00

417.12

99.08%

Gross Profit (PBDT)

1,648.63

6,540.00

-4,891.37

-74.79%

Depreciation

219.06

384.00

-164.94

-42.95%

Profit Before Tax

483.08

-38.00

521.08

1,371.26%

Tax

192.24

-102.00

294.24

288.47%

Provisions and contingencies

0.00

Profit After Tax

280.01

64.00

216.01

337.52%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

280.01

64.00

216.01

337.52%

Share in Profit of Associates

0.00

Minority Interest

10.84

0.00

10.84

Other related items

0.00

Consolidated Net Profit

290.85

64.00

226.85

354.45%

Equity Capital

0.00

Face Value

0.00

Reserves

14,817.47

9,796.00

5,021.47

51.26%

Earnings per share (EPS)

74.35

4.65

69.70

1,498.92%

Diluted Earnings per share

74.35

4.65

69.70

1,498.92%

Operating Profit Margin (Excl OI)

3.48%

1.58%

0.00

1.90%

Gross Profit Margin

5.04%

1.41%

0.00

3.63%

PAT Margin

2.01%

0.26%

0.00

1.75%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,393.32 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 3.12% vs 0.66% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 12.14% vs 9.77% in Nov 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 29.08 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 22.49% vs -47.69% in Aug 2025

YoY Growth in quarter ended Nov 2025 is -3.61% vs -20.12% in Nov 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 70.37 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 36.48% vs -18.20% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 22.79% vs -14.88% in Nov 2024

Quarterly - Interest

Interest 2.79 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 14.34% vs 11.42% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 58.52% vs 18.12% in Nov 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 3.48%

in Nov 2025

Figures in %

QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025

YoY Growth in quarter ended Nov 2025 has improved from Nov 2024